Gregory Bailey
CIK 1329505 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BHVN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 2001
HUNTSVILLE, AL 35806
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SER | Director | 1,897,445 | $1.35 | $2.56M | $504.8K | 16 | 2026-06-22 |
| BHVN | Director | 2,020,071 | $14.38 | $29.06M | -$23.12M | 35 | 2025-11-17 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | — | $11.10 | — | $0 | 2 | 2021-06-23 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 2,421,486 | — | — | -$20.84M | 34 | 2012-11-01 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 131,000 | — | — | $0 | 2 | 2008-06-30 |
| Acer Therapeutics Inc. (OPXA) Delisted | Director | — | — | — | $0 | 1 | 2007-06-21 |
Recent Filings · Page 3 of 10
92 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-02 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2024-04-25 | BHVN | Buy (P) | +25,503 | $999.2K | EDGAR |
| 2024-04-23 | BHVN | Buy (P) | +48,780 | $2.00M | EDGAR |
| 2024-04-04 | SER | Grant (A) | — | $0 | EDGAR |
| 2023-10-06 | BHVN | Buy (P) | +17,817 | $402.1K | EDGAR |
| 2023-05-04 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2022-10-26 | BHVN | Buy (P) | +200,000 | $2.10M | EDGAR |
| 2022-10-05 | — | Mixed | +1,307,971 | -$14 | |
| 2022-10-03 | BHVN | Disp (D) | −2,583,658 | -$383.67M | EDGAR |
| 2022-08-22 | BHVN | Buy (P) | +38,000 | $5.63M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.